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Dear Editor,
We received a blood grouping request for a 25-year-old primigravida diagnosed with ruptured ectopic pregnancy. She had no previous history of transfusion. Blood grouping was done by the tube technique and column agglutination technology (Diaclon ABO/D+ Reverse grouping, BioRad, Cressier, Switzerland). Forward grouping showed no agglutination with anti-A, anti-B and anti-A,B (Monoclonal antisera, Tulip Diagnostics, Goa, India) and 4+ agglutination was seen with anti-D (Monoclonal antisera, Tulip Diagnostics, Goa, India). Cell grouping was O RhD positive and serum grouping was AB group (Table 1) . Tube grouping results were further confirmed by gel technology. Thus, a blood group discrepancy was observed as the results of cell grouping and serum grouping were discordant. The patient's red cells were evaluated for the presence of the H antigen using commercial anti-H lectin (Tulip Diagnostics, Goa, India) and serum from a Bombay phenotype individual (in-house). The H antigen was not detected on patient's red cells. Further tests were performed to detect weak antigens and antibodies. When the tubes were incubated at 4 • C, there was no variation in the grade of agglutination with the cell grouping whereas the serum grouping tubes showed grade 1+ agglutination. Adsorption of patient's red cells with polyclonal antisera anti-A and anti-B at 4 • C and elution of the antibodies at 56 • C were performed to sense trace amounts of A and B antigens, respectively. Eluate was non-reactive with A cells and B cells, showing that there were no A and B antigens on patient's red cells. Furthermore, a saliva secretor test using hemagglutination inhibition was performed as described in the American Association of Blood Banks (AABB) technical manual, 17th edition. 1 She was a secretor of ABH substances in saliva. A red cell antibody screen using a commercial three-cell panel was negative.
She had no H antigen on red cells but secreted A, B and H substances in saliva. Based on these observations, her blood group was found to be AB para-Bombay phenotype (AB hsecretor). The specificity of the antibodies in the patient's serum is likely to be anti-HI (reacting at 4 • C only), as the serum did not react with group O cord cells (cord cells lack I antigen but carry H antigen) and was not inhibited by group O secretor saliva (anti-H would be inhibited by H substance). 2 Her biological sister's blood group was A 1 B RhD positive.
The H antigen is synthesized by ␣-(1,2)-fucosyltransferases encoded by two distinct but closely linked genes, FUT1 and FUT2. H antigen expression on red cells is dependent on FUT1 (the H gene). The FUT2 gene (Secretor gene) is responsible for the formation of the H antigen in secretions (salivary glands) and gastrointestinal/genitourinary tissues. Bombay and para-Bombay phenotypes arise due to the homozygous inheritance of non-functional FUT1 genes (hh allele). The two entities are distinguished by the presence or absence of the FUT2/Secretor gene. Bombay phenotype individuals are red cell H deficient non-secretors (hh, se/se), while para-Bombay individuals are red cell H-deficient secretors (hh, Se/Se or Se/se). 3 Para-Bombay individuals may occasionally have A and B antigens on red cells due to passive adsorption of A and B blood group substances from plasma. 4 Based on previous studies, the incidence of the Bombay phenotype in our population ranges from 1:2500 to 1:13,000. 5 When compared to the Bombay phenotype, the para-Bombay phenotype is more infrequent, occurring in a ratio of 1:15. 6 However, the exact incidence of para-Bombay phenotype is not known in our population. The incidence of the para-Bombay phenotype in the Chinese population has been documented to be 1:12,000. 2 Para-Bombay individuals can develop anti-H, anti-HI or both in addition to naturally occurring anti-A/anti-B. These antibodies have a wide thermal amplitude reacting at 4 • C, 22 • C and 37 • C (predominantly at 4 • C and 22 • C). 2, 4 These individuals should be transfused with Bombay or para-Bombay blood if allo-anti-H or anti-HI in their serum is clinically significant (i.e., reacting at 37 • C). It is also evident that anti-HI is clinically insignificant. For patients with anti-H/anti-HI reacting at lower temperatures (4 • C-22 • C), in case of nonavailability of the para-Bombay blood group, AHG compatible units of ABO blood groups can be transfused. 7 In our patient, the anti-HI reacted weakly at 4 • C only. One unit of A 1 B RhD positive packed red cells was cross-matched for this patient using LISS/Coombs gel card and found compatible, although she did not require a transfusion during this admission. In 8 Para-Bombay phenotype and its variants would be explored further in the event of performing a simple saliva secretor test, in addition to the use of anti-H lectin in blood grouping. Hence, it should be borne in mind that thorough analysis of any blood group discrepancy is warranted as it has significant clinical implications.
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